NDC 0069-2465
Abrysvo 0.06 mg per 0.5 mL injection, powder, lyophilized, for solution
On the label: Pfizer Laboratories Div Pfizer Inc.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Pfizer Manufacturing Belgium NV | Puurs-Sint-Amands, Belgium | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyJun 22, 2022 · 5 inspections |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Andover, MA, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyApr 8, 2026 · 5 inspections |
| Pfizer Ireland Pharmaceuticals Unlimited Company | Dublin, Ireland | Tests it | Problems found, fixed voluntarilyDec 15, 2023 · 5 inspections |
Product details
- Generic drug
- Recombinant Stabilized Rsv A Prefusion F Antigen and Recombinant Stabilized Rsv B Prefusion F Antigen: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intramuscular
- Strength
- 0.06 mg per 0.5 mL
- Approval
- BLA BLA125769
- On the market since
- Jul 30, 2024
- Package NDCs
0069-2465-010069-2465-100069-2465-19- Official label
- DailyMed (National Library of Medicine), updated Jul 14, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?